ES2153360T3 - Compuestos de isoxazol e de isotiazol que mejoran las funciones de razonamiento. - Google Patents
Compuestos de isoxazol e de isotiazol que mejoran las funciones de razonamiento.Info
- Publication number
- ES2153360T3 ES2153360T3 ES92912971T ES92912971T ES2153360T3 ES 2153360 T3 ES2153360 T3 ES 2153360T3 ES 92912971 T ES92912971 T ES 92912971T ES 92912971 T ES92912971 T ES 92912971T ES 2153360 T3 ES2153360 T3 ES 2153360T3
- Authority
- ES
- Spain
- Prior art keywords
- compounds
- isotiazol
- isoxazol
- treatment
- reasoning functions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
SE PRESENTAN ANTAGONISTAS NICOTINICOS Y SELECTIVOS DE LA FORMULA I O LAS SALES FARMACOLOGICAMENTE ACEPTABLES DE LOS MISMOS, UTILES EN EL TRATAMIENTO DE ENFERMEDADES COGNITIVAS, NEUROLOGICAS Y MENTALES QUE SE CARACTERIZAN POR UNA FUNCION COLINERGICA DISMINUIDA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70692091A | 1991-05-29 | 1991-05-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2153360T3 true ES2153360T3 (es) | 2001-03-01 |
Family
ID=24839628
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES92912971T Expired - Lifetime ES2153360T3 (es) | 1991-05-29 | 1992-05-28 | Compuestos de isoxazol e de isotiazol que mejoran las funciones de razonamiento. |
Country Status (13)
Country | Link |
---|---|
US (1) | US5409946A (es) |
EP (1) | EP0588917B1 (es) |
JP (1) | JP3153551B2 (es) |
AT (1) | ATE197454T1 (es) |
BR (1) | BR1100981A (es) |
CA (1) | CA2109585C (es) |
DE (1) | DE69231557T2 (es) |
DK (1) | DK0588917T3 (es) |
ES (1) | ES2153360T3 (es) |
GR (1) | GR3035285T3 (es) |
IE (1) | IE921690A1 (es) |
PT (1) | PT100525B (es) |
WO (1) | WO1992021339A1 (es) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08502508A (ja) * | 1992-10-23 | 1996-03-19 | メルク シヤープ エンド ドーム リミテツド | ドーパミンレセプターサブタイプリガンド |
US5424444A (en) * | 1992-11-25 | 1995-06-13 | Abbott Laboratories | Method of preparing enantiomerically-pure 3-methyl-5-(1-alkyl-2(S)-pyrrolidinyl) isoxazoles |
US5494680A (en) * | 1993-12-08 | 1996-02-27 | Minnesota Mining And Manufacturing Company | Transdermal delivery device |
US5705512A (en) * | 1994-11-10 | 1998-01-06 | Sibia Neurosciences, Inc. | Modulators of acetylcholine receptors |
US5677459A (en) * | 1994-11-10 | 1997-10-14 | Sibia Neurosciences, Inc. | Methods for the preparation of modulators of acetylcholine receptors |
US5594011A (en) * | 1994-11-10 | 1997-01-14 | Sibia Neurosciences, Inc. | Modulators of acetylcholine receptors |
US5703100A (en) * | 1994-11-10 | 1997-12-30 | Sibia Neurosciences, Inc. | Modulators of acetylcholine receptors |
US5723477A (en) * | 1994-11-10 | 1998-03-03 | Sibia Neurosciences, Inc. | Modulators of acetylcholine receptors |
US5824692A (en) * | 1995-01-06 | 1998-10-20 | Lippiello; Patrick Michael | Pharmaceutical compositions for prevention and treatment of central nervous system disorders |
DE19501022C1 (de) * | 1995-01-14 | 1996-06-05 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System zur Verabreichung von (s)-3-Methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen Salze und Verfahren zu seiner Herstellung |
WO1996030372A1 (fr) * | 1995-03-24 | 1996-10-03 | Japan Tobacco Inc. | Derives diazabicyclo[3.3.1]nonane et leurs intermediaires, leur application therapeutique et procedes de production |
US6194581B1 (en) | 1995-04-07 | 2001-02-27 | Merck & Co., Inc. | Substituted pyridines useful as modulators of acetylcholine receptors |
US5583140A (en) * | 1995-05-17 | 1996-12-10 | Bencherif; Merouane | Pharmaceutical compositions for the treatment of central nervous system disorders |
US5794887A (en) | 1995-11-17 | 1998-08-18 | Komerath; Narayanan M. | Stagnation point vortex controller |
US5723414A (en) * | 1996-01-24 | 1998-03-03 | Rohm And Haas Company | 5-aryl-isoxazolinones and herbicidal use thereof |
ATE416164T1 (de) | 1996-04-23 | 2008-12-15 | Targacept Inc | Pharmazeutische zusammenstellungen zur prävention und behandlung von zns-erkrankungen |
US5706829A (en) * | 1996-06-06 | 1998-01-13 | Creighton University | Method for treating neurocardiogenic syncope |
US5760049A (en) * | 1997-02-21 | 1998-06-02 | Synapse Pharmaceuticals International, Inc. | Method for controlling tobacco use and alleviating withdrawal symptoms due to cessation of tobacco use |
US6166032A (en) * | 1997-02-07 | 2000-12-26 | Synapse Pharmaceuticals International, Inc. | Method for controlling tobacco use and alleviating withdrawal symptoms due to cessation of tobacco use |
CN1205210C (zh) | 1997-05-30 | 2005-06-08 | 神经研究公司 | 作为尼古丁ACh受体上胆碱能配体的9-氮杂双环(3.3.1)壬-2-烯衍生物 |
CZ298824B6 (cs) | 1997-05-30 | 2008-02-20 | Neurosearch A/S | Deriváty 8-azabicyklo[3.2.1]okt-2-enu, zpusob jejich prípravy a jejich použití |
CA2289576A1 (en) | 1997-05-30 | 1998-12-03 | Neurosearch A/S | Azacyclooctane and heptane derivatives, their preparation and use in therapy |
US7214686B2 (en) | 1997-06-30 | 2007-05-08 | Targacept, Inc. | Pharmaceutical compositions and methods for effecting dopamine release |
US6133002A (en) | 1997-09-25 | 2000-10-17 | Dsm N.V. | Process for preparing optically active 2-amino-ω-oxoalkanoic acid derivatives |
US6218383B1 (en) | 1998-08-07 | 2001-04-17 | Targacept, Inc. | Pharmaceutical compositions for the prevention and treatment of central nervous system disorders |
EP1274444B1 (en) * | 2000-03-16 | 2013-05-15 | THE McLEAN HOSPITAL CORPORATION | Cdp-choline and uridine for the treatment of alcohol abuse |
WO2004043229A2 (en) * | 2002-11-08 | 2004-05-27 | The Mclean Hospital Corporation | Compounds for the treatment of tobacco dependence and withdrawal |
UA88869C2 (ru) * | 2002-12-20 | 2009-12-10 | Зе Маклин Хоспитал Корпорейшн | Соединения для нормализации цикла сон/бессонница |
WO2005034874A2 (en) * | 2003-10-08 | 2005-04-21 | The Mclean Hospital Corporation | Enhanced efficacy of omega-3 fatty acid therapy in the treatment of psychiatric disorders and other indications |
US20050129710A1 (en) * | 2003-10-08 | 2005-06-16 | Renshaw Perry F. | Methods of treating psychiatric substance abuse, and other disorders using combinations containing omega-3 fatty acids |
EP1678172B1 (en) | 2003-10-15 | 2009-12-09 | Targacept, Inc. | Azabicyclic compounds for relieving pain and treating central nervous system disorders |
FR2862647B1 (fr) * | 2003-11-25 | 2008-07-04 | Aventis Pharma Sa | Derives de pyrazolyle, procede de preparation et intermediaires de ce procede a titre de medicaments et de compositions pharmaceutiques les renfermant |
US7737128B2 (en) * | 2004-06-10 | 2010-06-15 | The Mclean Hospital Corporation | Pyrimidines, such as uridine, in treatments for patients with bipolar disorder |
EP1765364A4 (en) * | 2004-06-10 | 2010-09-22 | Mclean Hospital Corp | PYRIMIDINES, SUCH AS Z: B: CYTIDINE, IN THE TREATMENT OF PATIENTS WITH BIPOLAR DISORDER |
US7947661B2 (en) * | 2004-08-11 | 2011-05-24 | The Mclean Hospital Corporation | Compounds for the treatment of marihuana dependence, withdrawal, and usage |
EP1802258A4 (en) | 2004-09-13 | 2015-09-23 | Chrono Therapeutics Inc | BIOSYNCHRONE TRANSDERMAL MEDICINES |
CN101772346B (zh) | 2007-04-02 | 2014-05-07 | 帕金森氏病研究院 | 用于降低治疗副作用的方法和组合物 |
US20100041621A1 (en) * | 2008-08-15 | 2010-02-18 | Perry Renshaw | Methods and compositions for improving cognitive performance |
WO2010030887A1 (en) * | 2008-09-11 | 2010-03-18 | Catholic Healthcare West | Nicotinic attenuation of cns inflammation and autoimmunity |
WO2011085406A1 (en) | 2010-01-11 | 2011-07-14 | Mithridion, Inc. | Compounds and compositions for cognition-enhancement, methods of making, and methods of treating |
WO2012033956A1 (en) | 2010-09-08 | 2012-03-15 | Mithridion, Inc. | Cognition enhancing compounds and compositions, methods of making, and methods of treating |
US9006462B2 (en) | 2013-02-28 | 2015-04-14 | Dermira, Inc. | Glycopyrrolate salts |
JP6114841B2 (ja) | 2013-02-28 | 2017-04-12 | ダーミラ, インク.Dermira, Inc. | グリコピロレート塩 |
JP2018511355A (ja) | 2015-01-28 | 2018-04-26 | クロノ セラピューティクス インコーポレイテッドChrono Therapeutics Inc. | 薬剤送達方法及びシステム |
US11285306B2 (en) | 2017-01-06 | 2022-03-29 | Morningside Venture Investments Limited | Transdermal drug delivery devices and methods |
EP3801732A4 (en) | 2018-05-29 | 2022-04-27 | Morningside Venture Investments Limited | DRUG DELIVERY METHODS AND SYSTEMS |
-
1992
- 1992-05-28 DE DE69231557T patent/DE69231557T2/de not_active Expired - Lifetime
- 1992-05-28 JP JP50062493A patent/JP3153551B2/ja not_active Expired - Fee Related
- 1992-05-28 CA CA002109585A patent/CA2109585C/en not_active Expired - Lifetime
- 1992-05-28 AT AT92912971T patent/ATE197454T1/de not_active IP Right Cessation
- 1992-05-28 WO PCT/US1992/004631 patent/WO1992021339A1/en active IP Right Grant
- 1992-05-28 EP EP92912971A patent/EP0588917B1/en not_active Expired - Lifetime
- 1992-05-28 PT PT100525A patent/PT100525B/pt active IP Right Grant
- 1992-05-28 ES ES92912971T patent/ES2153360T3/es not_active Expired - Lifetime
- 1992-05-28 DK DK92912971T patent/DK0588917T3/da active
- 1992-07-01 IE IE169092A patent/IE921690A1/en not_active IP Right Cessation
-
1993
- 1993-09-08 US US08/118,079 patent/US5409946A/en not_active Expired - Lifetime
-
1997
- 1997-05-14 BR BR1100981-0A patent/BR1100981A/pt active IP Right Grant
-
2001
- 2001-01-24 GR GR20010400099T patent/GR3035285T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
GR3035285T3 (en) | 2001-04-30 |
CA2109585A1 (en) | 1992-12-10 |
EP0588917A1 (en) | 1994-03-30 |
DE69231557T2 (de) | 2001-06-21 |
EP0588917A4 (es) | 1994-04-13 |
PT100525B (pt) | 1999-10-29 |
PT100525A (pt) | 1993-09-30 |
EP0588917B1 (en) | 2000-11-08 |
DE69231557D1 (de) | 2000-12-14 |
US5409946A (en) | 1995-04-25 |
CA2109585C (en) | 2000-02-15 |
IE921690A1 (en) | 1992-12-02 |
JPH06508143A (ja) | 1994-09-14 |
DK0588917T3 (da) | 2001-02-12 |
JP3153551B2 (ja) | 2001-04-09 |
WO1992021339A1 (en) | 1992-12-10 |
ATE197454T1 (de) | 2000-11-11 |
BR1100981A (pt) | 2000-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2153360T3 (es) | Compuestos de isoxazol e de isotiazol que mejoran las funciones de razonamiento. | |
ES2169727T3 (es) | Compuestos heterociclicos de eter que mejoran la funcion cognitiva. | |
NL300128I2 (nl) | Gesubstitueerde isoxazolen voor de behandeling vanontsteking. | |
NO960380D0 (no) | Middel til behandling av neurosykdommer | |
HU9203619D0 (en) | Isoxazole-4-carboxylic acid amides and hydroxi-alkylidene-cyanic-acetic acid amides and pharmaceutical preparatives containing them | |
ATE198891T1 (de) | Thienobenzodiazepinderivate zur behandlung von störungen des zentralnervensystems | |
DE69615558D1 (de) | Zns-aktive semicarbazone und diese enthaltende pharmazeutische zubereitungen | |
KR920021145A (ko) | 뇌 글루타메이트의 과다방출의 억제에 유용한 제형 | |
PT649846E (pt) | Derivados da galantamina processo para a sua preparacao e sua utilizacao como medicamentos | |
NO943521L (no) | Anvendelse av et pyrrolidinacetamidderivat for fremstilling av et terapeutikum | |
DE69115526D1 (de) | 2,4-Pyrimidindionderivate und diese enthaltende Arzneimittel | |
DE69625709D1 (de) | Alpha-substituierte heterozyklische benzylderivate, zwischenverbindungen zu ihrer herstellung und pestizide die diese als aktiver bestandteil enthalten | |
DE59408453D1 (de) | Pyrido-pyrimidindione, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
ATE73785T1 (de) | 5-(3-alkyl-5-tert.butyl-4-hydroxyphenyl)-2-amin - 6h-1,3,4-thiadiazine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung. | |
SE8503109D0 (sv) | Cyclic prodrugs of antiinflammatory oxicams | |
KR960700249A (ko) | 축합된 벤조(d)이속사졸 유도체 및 정신에 작용하는 제제로서 이것의 사용방법(condensed bevzo(d)isoxazole derivatives and their use as psychoactive agents) | |
DE59104473D1 (de) | Arzneimittel welche substituierte 2-Cyclohexen-1yl-amin-Derivate enthalten und ihre Verwendung zur Bekämpfung von Krankheiten. | |
DK0514267T3 (da) | Hidtil ukendte amidderivater af 1-aminooctahydropyrido(2,1-c)(1,4)oxazin, fremgangsmåder til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
DE69110440D1 (de) | 1,2,3,4-Tetrahydronaphthylaminderivate mit nootroper Aktivität und diese enthaltenden Arzneimittel. | |
TH20039B (th) | อนุพันธ์แอนธราไซคลิน | |
TH16153B (th) | การใช้เวนลาแฟกซีนหรือสารประกอบแอริลออกซิ โพรแพแนมีนในการผลิตยาสำหรับการรักษาการกลั้นปัสสาวะไม่อยู่ | |
TH18473A (th) | การใช้เวนลาแฟกซีนหรือสารประกอบแอริลออกซิ โพรแพแนมีนในการผลิตยาสำหรับการรักษาการกลั้นปัสสาวะไม่อยู่ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 588917 Country of ref document: ES |